COMMUNIQUÉS West-GlobeNewswire

Transactions under Novozymes’ stock buyback program
11/06/2018
Please read the full announcement in the attached PDF Attachment 2018_38_Stock_Buybackprogram_EN
Novo Nordisk A/S - Share repurchase programme
11/06/2018
Bagsværd, Denmark, 11 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Tetraphase Pharmaceuticals Announces Data from a Pooled Analysis of IGNITE1 and IGNITE4 Phase 3 Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections at the ASM Microbe 2018 Annual Meeting
11/06/2018
Eravacycline Global Surveillance and TP-6076 Data Also Highlighted WATERTOWN, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing [...]
Dynavax to Present at the William Blair 38th Annual Growth Stock Conference
11/06/2018
BERKELEY, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that Michael Ostrach, Dynavax’s Chief Financial Officer, will present at the William Blair 38th Annual [...]
Vical Reports Phase 2 Trial of HSV-2 Therapeutic Vaccine Did Not Meet Primary Endpoint
11/06/2018
Company to focus on advancing VL-2397 and other pipeline opportunities SAN DIEGO, June 11, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced top-line results from a randomized, double-blind, [...]
Fennec Pharmaceuticals Set to Join Russell 3000 Index
11/06/2018
RESEARCH TRIANGLE PARK, N.C., June 11, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX), a specialty pharmaceutical company focused on the development of PEDMARK TM (a unique formulation of [...]
Solon Eiendom ASA : Primary insider notification
11/06/2018
(Oslo, Norway, 11 June 2018) Reference is made to Solon Eiendom ASA's (the "Company") prospectus dated 16 May 2018 (the "Prospectus") for inter alia the subsequent offering (the "Subsequent Offering") of up to 396,040 [...]
Solon Eiendom ASA : Final result of the subsequent offering
11/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Summit Therapeutics Unveils Second Novel Target for Gonorrhoea at ASM Microbe 2018
11/06/2018
Summit Therapeutics plc ("Summit" or the "Company") Summit Unveils Second Novel Target for Gonorrhoea at ASM Microbe 2018 Highlights the Power of the Discuva Platform to Identify Novel Antibiotic Targets Oxford, UK, and [...]
Shire plc : Rule 2.9 Announcement
11/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 11 June 2018 Shire [...]
Saniona plans Phase 2a study for treatment of Hypothalamic Obesity
11/06/2018
PRESS RELEASE June 11, 2018 Saniona, a leading biotech company within ion-channel research, today announced that it plans to initiate a clinical Phase 2a study in the rare eating disorder hypothalamic obesity with its [...]
Motif Bio Announces New Iclaprim Data Presented at ASM Microbe 2018
11/06/2018
Pooled efficacy and safety data from REVIVE Phase 3 trials presented Data also published in peer-reviewed journal, International Journal of Antimicrobial Agents NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc [...]
Sanofi Launches "Action 2018", a Worldwide Employee Stock Purchase Plan
11/06/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Launches "Action 2018", a Worldwide Employee Stock Purchase Plan A plan taking place in almost 80 countries Subscription per five shares entitle the [...]
Sanofi lance « Action 2018 », un plan mondial d'actionnariat salarié
11/06/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi lance « Action 2018 », un plan mondial d'actionnariat salarié Un plan déployé dans près de 80 pays Un abondement de l'entreprise par tranche de [...]
Idorsia initiates a Phase 3 registration program with nemorexant (ACT-541468) for the treatment of insomnia
11/06/2018
Idorsia to host an investor webcast to discuss the Phase 3 program today at 14:00hrs CEST Allschwil, Switzerland - June 11, 2018 Idorsia Ltd (SIX: IDIA) today announced that the first patients have been enrolled into [...]
Innate Pharma to present at the Bryan Garnier 3rd Annual Oncology Day on June 13, 2018
11/06/2018
Innate Pharma to present at the Bryan Garnier 3rd Annual Oncology Day on June 13, 2018 Marseille, France, June 11, 2018, 07:00 AM CEST Innate Pharma (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces [...]
Innate pharma à la 3ème journée Oncologie de Bryan Garnier le 13 juin 2018
11/06/2018
Innate pharma à la 3ème journée Oncologie de Bryan Garnier le 13 juin 2018 Marseille le 11 juin 2018, 7h00 CEST Innate Pharma SA (la « Société » - Euronext Paris : FR0010331421 - IPH) annonce aujourd'hui qu'elle sera [...]
Bone Therapeutics SA : Information on the total number of voting rights and shares
11/06/2018
Regulated information Information on the total number of voting rights and shares Gosselies, Belgium, 11 June 2018, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d'actions
11/06/2018
Information réglementée Information relative au nombre total de droits de vote et d'actions Gosselies, Belgique, le 11 juin 2018, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de [...]

Pages